Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry

京东健康公布2022年中期业绩:线下DTP药房拓展至全国26省 满足用户全场景用药需求
JD Health announced mid-term results in 2022: offline DTP pharmacy expanded to 26 provinces across the country to meet users' full-scene drug needs.

投资者网 ·  {{timeTz}}

2022年8月23日,京东健康发布2022年中期业绩公告。报告期内,京东健康总收入为人民币202亿元,同比增长48.3%,非国际财务报告准则指标下(Non-IFRS)净利润达12.1亿元,同比增长82.0%;截至2022年6月30日,过去12个月的年度活跃用户数量超过1.31亿,相比于截至2021年6月30日的年度活跃用户数净增加超过2,270万。

On August 23, 2022, JD Health issued the 2022 interim results announcement. During the reporting period, JD Health's total income was 20.2 billion yuan, an increase of 48.3 percent over the same period last year, and the net profit under non-International Financial reporting Standards (Non-IFRS) reached 1.21 billion yuan, an increase of 82.0 percent over the same period last year. As of June 30, 2022, the number of annual active users in the past 12 months exceeded 131 million, compared with a net increase of more than 22.7 million.

公告显示,京东健康在上半年持续强化全渠道供应链体系建设,进一步提升供应链管理能力和效率,通过以京东大药房为核心的医药健康零售业务,不断发挥数智化社会供应链效能;一方面为用户提供一站式专业化服务体验,另一方面与药企等生态伙伴携手,共同加速医药健康行业数字化转型。

According to the announcement, JD Health continued to strengthen the construction of omni-channel supply chain system in the first half of the year, further improving the ability and efficiency of supply chain management, through the pharmaceutical health retail business with JD.com Pharmacy as the core, continue to give full play to the effectiveness of the digital social supply chain; on the one hand, provide users with one-stop professional service experience, on the other hand, join hands with pharmaceutical companies and other ecological partners to accelerate the digital transformation of the pharmaceutical and health industry.

持续强化医药健康全渠道供应链能力

Continuously strengthen the capacity of pharmaceutical health omni-channel supply chain

2022年上半年,京东健康不断强化自营、在线平台和全渠道业务的协同效应,在持续丰富医药健康商品品类的基础上,全面夯实医药健康全渠道供应链能力。

In the first half of 2022, JD Health continuously strengthened the synergy of self-management, online platform and omni-channel business, and comprehensively consolidated the capacity of pharmaceutical and health omni-channel supply chain on the basis of continuously enriching the categories of pharmaceutical and health commodities.

截至2022年6月30日,京东健康使用了京东物流全国范围内的20个药品仓库和超过450个非药品仓库,京东大药房药品“自营冷链”能力已覆盖全国超240个城市,京东大药房线下DTP药房拓展至全国26个省级行政区,在有效提升冷链药品种类和履约能力的同时,为用户提供更加专业、高效的一站式体验。

As of June 30,2022, JD Health has used JD Logistics, Inc. 's 20 pharmaceutical warehouses and more than 450non-pharmaceutical warehouses across the country. JD.com Pharmacy's "self-supporting cold chain" capability has covered more than 240cities across the country. JD.com 's offline DTP pharmacy has been expanded to 26 provincial administrative regions across the country, effectively improving cold chain drug types and compliance capabilities, while providing users with a more professional and efficient one-stop experience.

2022年上半年,京东健康与国内外领先的多家药企深化合作,成为众多医药品牌加快数字化运营及开展数字化创新项目的重要合作伙伴,同时多家药企新特药在京东大药房在线首发。其中,包括诺华制药、百济神州、鲁南制药、恒瑞医药等多家药企的自营旗舰店也正式上线,为更多慢病患者提供专业高效的一站式服务。

In the first half of 2022, JD Health deepened cooperation with a number of leading pharmaceutical companies at home and abroad, and became an important partner for many pharmaceutical brands to speed up digital operations and carry out digital innovation projects. at the same time, a number of pharmaceutical companies launched new specialties online at JD.com Pharmacy. Among them, the self-operated flagship stores of many pharmaceutical companies, including Novartis AG, BeiGene, Ltd., Lunan Pharmaceutical and Hengrui Pharmaceutical, have also been officially launched to provide professional and efficient one-stop services for more chronically ill patients.

值得关注的是,京东健康还与同仁堂科技、齐鲁制药、远大制药等围绕医药产品全生命周期开展“真实世界研究”项目合作,共同促进临床研究及诊疗水平的提升。截至2022年6月30日,京东健康携手CRO公司(合同研究组织),以及众多药企成立的“京东健康临床试验患者招募中心”,已累计上线超过400项正在研发的I-III期临床试验项目,为新药研发和上市提速增效。

What is noteworthy is that JD Health also cooperated with Tongrentang Technology, Qilu Pharmaceutical and Broad Pharmaceutical to carry out "real world research" projects around the whole life cycle of pharmaceutical products to jointly promote the improvement of clinical research and diagnosis and treatment. As of June 30, 2022, JD Health, together with CRO (contract research organization) and the JD Health Clinical trial patient recruitment Center set up by many pharmaceutical companies, has launched more than 400 phase I-III clinical trial projects under development to speed up new drug research and development and market efficiency.

在医疗器械、营养保健及传统滋补等健康品领域,京东健康持续聚焦消费者精细化、专业化需求,打造多样化健康消费场景。报告期内,京东健康与同仁堂健康、汤臣倍健等全球领先企业建立战略合作,并为其提供全域营销解决方案;还与热景生物、万泰生物、乐普诊断等多家国内首批获得新冠抗原自测产品批准的企业达成合作,成为其首家线上合作伙伴。

In the field of health products such as medical devices, nutrition and health care, and traditional nourishment, JD Health continues to focus on the fine and professional needs of consumers, creating diversified and healthy consumption scenarios. During the reporting period, JD Health established strategic cooperation with Tongrentang Health, Tomson Baijian and other global leading companies, and provided them with global marketing solutions. It also cooperated with Rejing Biology, Wantai Biology, Lepu Diagnostics and other domestic enterprises that were approved by COVID-19 antigen self-test products, and became its first online partner.

京东健康还助力合作商家进行全方位的经营数字化升级。今年618期间,共有超过400个合作商家成交额同比增长翻倍;全渠道服务“京东药急送”通过与商家共建网格化运营生态和多种履约方式,已携手超6万商家、为超过400个城市的用户提供全时段、全渠道的便捷服务。 

JD Health also helps cooperative merchants to upgrade their business digitally in all directions. During the 618 period this year, the turnover of more than 400 cooperative merchants doubled compared with the same period last year. "Jingdong Drug Express delivery", an omni-channel service, has joined hands with more than 60,000 merchants to provide full-time and omni-channel convenient services for users in more than 400 cities by jointly building a grid-based operation ecology and a variety of implementation methods.

不断打磨一站式专业化服务体验

Constantly polish the experience of one-stop professional service

2022年上半年,京东健康注重提升专业化服务能力,不断在疾病科普、单病种管理、药事服务等领域取得新进展。

In the first half of 2022, JD Health focused on improving the ability of professional service, and continuously made new progress in the fields of disease science popularization, single disease management, pharmaceutical care, and so on.

2022年2月,为了进一步缓解罕见病患者群体所面临的难题,在京东大药房罕见病关爱中心上线一周年之际,京东健康正式启动“罕见病全生态服务战略”,通过携手产业链各方,共同打造罕见病全生态服务平台,持续在服务患者、新药上市、疾病确诊、医生培训、慈善援助等方面深化生态服务能力建设。

In February 2022, in order to further alleviate the problems faced by patients with rare diseases, on the occasion of the first anniversary of the launch of the care center for rare diseases at JD.com Pharmacy, JD Health officially launched the "all-ecological service strategy for rare diseases" by joining hands with all parties in the industrial chain. work together to build a full ecological service platform for rare diseases We will continue to deepen capacity-building for ecological services in the areas of patient service, new drug marketing, disease diagnosis, doctor training, and charitable assistance.

京东健康不断深入单病种患者群体,深耕院外药事服务。2022年5月,京东健康从医患沟通、医生义诊、健康科普、健康监测等四大领域全面升级京东大药房单病种关爱中心。截至目前,京东大药房已上线13个单病种关爱中心,对应的疾病数量超过24个。数据显示,上线一年多来,京东大药房糖尿病、痛风等关爱中心用户人均用药天数平均提高62%,患者用药依从性得到明显提升,因处方错误、擅自停药或加减药量引发健康问题的现象得到了有效遏制。

JD Health is constantly going deep into the group of patients with single disease and ploughing out-of-hospital pharmaceutical services. In May 2022, JD Health comprehensively upgraded JD.com 's single disease care center in four major fields, including doctor-patient communication, doctor free clinic, health science popularization, and health monitoring. Up to now, JD.com Pharmacy has launched 13 single disease care centers, corresponding to more than 24 diseases. Data show that since it was launched more than a year ago, the average number of days per user of care centers such as diabetes and gout in JD.com Pharmacy has increased by 62% on average, and patients' compliance with medication has been significantly improved. The phenomenon of health problems caused by prescription errors, unauthorized withdrawal of drugs, or addition or reduction of drugs has been effectively curbed.

此外,为了更好地引导和帮助用户合理用药、保障民众用药安全,2022年6月,京东健康打磨已久的“药学门诊”正式上线。通过与具有临床药学经验的执业药师合作,“京东健康药学门诊”能为用户提供药物治疗评价、诊后用药方案调整、药物治疗方案随访、药学知识科普等一系列专业化在线药学服务,通过结合用户个体和特殊情况,帮助其在院外一站式解决诊后用药问题。

In addition, in order to better guide and help users to use drugs rationally and ensure the safety of drug use among the public, JD Health's long-polished "Pharmacy Clinic" was officially launched in June 2022. By cooperating with licensed pharmacists with clinical pharmaceutical experience, JD Health Pharmaceutical Clinic can provide users with a series of professional online pharmaceutical services, such as drug treatment evaluation, post-diagnosis medication plan adjustment, drug treatment plan follow-up, pharmaceutical knowledge popularization, and so on. by combining individual users and special conditions, help them to solve the problem of post-diagnosis medication outside the hospital.

京东健康表示,在持续深化医药健康一站式专业化服务体验的过程中,京东健康特别重视构建和完善用户全场景用药的安全体验。京东健康的全职药师和医生团队,将与线下医院合作临床药师形成优势互补,并通过数字化、智能化技术手段,共同打造安全、专业、全面的用药服务体系,进一步加强用户诊后用药随访管理以及居家药学服务体验。

JD Health said that in the process of continuously deepening the one-stop professional service experience of medicine and health, JD Health pays special attention to building and improving the safety experience of users using drugs in the whole scene. JD Health's full-time team of pharmacists and doctors will complement each other with the advantages of clinical pharmacists in cooperation with offline hospitals, and jointly create a safe, professional and comprehensive drug use service system by means of digital and intelligent technology. we will further strengthen the follow-up management of drug use after diagnosis and the experience of home pharmaceutical care.

This page is machine-translated. Moomoo tries to improve but do not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose of the above content.

Moomoo is a financial information and trading app offered by Moomoo Technologies Inc.
In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).
In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial Singapore Pte. Ltd. is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.
In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our websites https://www.futuau.com and https://www.moomoo.com/au. Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd. and Futu Securities (Australia) Ltd are affiliated companies.